1. Home
  2. DCTH vs ALLT Comparison

DCTH vs ALLT Comparison

Compare DCTH & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • ALLT
  • Stock Information
  • Founded
  • DCTH 1988
  • ALLT 1996
  • Country
  • DCTH United States
  • ALLT Israel
  • Employees
  • DCTH N/A
  • ALLT N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • ALLT Telecommunications Equipment
  • Sector
  • DCTH Health Care
  • ALLT Telecommunications
  • Exchange
  • DCTH Nasdaq
  • ALLT Nasdaq
  • Market Cap
  • DCTH 388.3M
  • ALLT 342.5M
  • IPO Year
  • DCTH N/A
  • ALLT 2006
  • Fundamental
  • Price
  • DCTH $10.67
  • ALLT $9.19
  • Analyst Decision
  • DCTH Strong Buy
  • ALLT Buy
  • Analyst Count
  • DCTH 4
  • ALLT 1
  • Target Price
  • DCTH $24.50
  • ALLT N/A
  • AVG Volume (30 Days)
  • DCTH 485.5K
  • ALLT 578.3K
  • Earning Date
  • DCTH 11-07-2025
  • ALLT 08-14-2025
  • Dividend Yield
  • DCTH N/A
  • ALLT N/A
  • EPS Growth
  • DCTH N/A
  • ALLT N/A
  • EPS
  • DCTH 0.06
  • ALLT N/A
  • Revenue
  • DCTH $70,240,000.00
  • ALLT $95,342,000.00
  • Revenue This Year
  • DCTH $159.22
  • ALLT $10.64
  • Revenue Next Year
  • DCTH $41.22
  • ALLT $15.76
  • P/E Ratio
  • DCTH $193.75
  • ALLT N/A
  • Revenue Growth
  • DCTH 491.35
  • ALLT 4.74
  • 52 Week Low
  • DCTH $8.08
  • ALLT $2.78
  • 52 Week High
  • DCTH $18.23
  • ALLT $10.77
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 43.30
  • ALLT 65.49
  • Support Level
  • DCTH $10.60
  • ALLT $8.53
  • Resistance Level
  • DCTH $11.38
  • ALLT $9.58
  • Average True Range (ATR)
  • DCTH 0.44
  • ALLT 0.43
  • MACD
  • DCTH 0.01
  • ALLT 0.15
  • Stochastic Oscillator
  • DCTH 5.26
  • ALLT 81.07

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

Share on Social Networks: